<div class="welcome-screen" id="welcomeScreen">
    <div class="welcome-banner">
        <h1 id="welcome-title">Welcome to the page on viral STDs!</h1>
        <p id="welcome-description">Explore the genital warts, HIV/AIDS and herpes.</p>
    </div>
    
    <div class="explanation-card">
        <h1>Genital Warts (HPV)</h1>
        <h2>Human Papillomavirus: Pathophysiology and Clinical Management</h2>
        <h3>Etiology and Epidemiology</h3>
        <p>Genital warts are caused primarily by low-risk HPV types <b>6 and 11</b>, which account for approximately 90% of external anogenital warts. HPV is a <b>non-enveloped, double-stranded DNA virus</b> in the Papillomaviridae family. It is transmitted via <b>direct epithelial contact</b>, with a high prevalence among sexually active individuals aged 15–30 years.</p>
        <h3>Pathogenesis</h3>
        <ol>
            <li>HPV infects <b>basal keratinocytes</b> through microabrasions in the mucosa.</li>
            <li>Viral replication induces cellular proliferation, leading to the characteristic verrucous lesions.</li>
            <li>Low-risk types remain episomal (non-integrating), while high-risk types can integrate into the host genome.</li>
        </ol>
        <h3>Clinical Features</h3>
        <ol>
            <li>Exophytic, flesh-colored to hyperpigmented, <b>cauliflower-like verrucous lesions</b> on the vulva, perineum, penis, perianal area, and urethra.</li>
            <li>Often <b>asymptomatic</b>, but can be associated with pruritus, pain, or bleeding during intercourse or defecation.</li>
            <li>In immunocompromised patients, lesions may be more extensive and refractory to treatment.</li>
        </ol>
        <h3>Diagnosis</h3>
        <ol>
            <li>Primarily clinical based on morphology and anatomical distribution.</li>
            <li><b>Colposcopy</b> may be used to evaluate subclinical lesions, especially in high-risk patients.</li>
            <li>Biopsy indicated if atypical appearance, rapid growth, ulceration, or suspicion of malignancy.</li>
        </ol>
        <h3>Treatment</h3>
        <ol>
            <li>Patient-applied: <b>Imiquimod 5% cream</b>, podophyllotoxin, sinecatechins.</li>
            <li>Provider-administered: <b>Cryotherapy</b>, trichloroacetic acid, electrosurgery, CO₂ laser therapy, surgical excision.</li>
            <li>HPV vaccination (Gardasil 9) is recommended for all individuals up to age 26; covers both low-risk and high-risk types.</li>
        </ol>
    </div>
    
    <div class="question-card">
        <h1>Question 1</h1>
        <p>Which HPV types are most commonly associated with anogenital warts?</p>
        <ul class="options" id="options">
            <li data-answer="correct">HPV 6 and 11</li>
            <li data-answer="wrong">HPV 16 and 18</li>
            <li data-answer="wrong">HPV 31 and 33</li>
        </ul>
    </div>
    
    <div class="explanation-card">
        <h1>Genital Herpes (HSV)</h1>
        <h2>Herpes Simplex Virus Infection: Diagnosis and Management</h2>
        <h3>Etiology and Pathophysiology</h3>
        <p>Genital herpes is caused by <b>HSV-2</b> in approximately 70–90% of cases and <b>HSV-1</b> in the remaining. After primary infection, HSV establishes latency in <b>sacral dorsal root ganglia</b> with periodic reactivation. Shedding can occur even in the absence of visible lesions.</p>
        <h3>Clinical Features</h3>
        <ol>
            <li>Primary infection: <b>Painful grouped vesicles</b> on an erythematous base, progressing to ulcers; may be associated with fever, dysuria, tender lymphadenopathy, and malaise.</li>
            <li>Recurrent episodes: Typically milder and shorter; prodrome of <b>tingling or burning</b> precedes lesions.</li>
            <li>Complications include urinary retention, autoinoculation (herpetic whitlow), and neonatal herpes in peripartum transmission.</li>
        </ol>
        <h3>Diagnosis</h3>
        <ol>
            <li><b>PCR</b> from swabbed lesion is gold standard due to high sensitivity and specificity.</li>
            <li><b>Tzanck smear</b> shows multinucleated giant cells but lacks specificity.</li>
            <li>Serology may assist in differentiating HSV-1 vs HSV-2 but not helpful in acute diagnosis.</li>
        </ol>
        <h3>Treatment</h3>
        <ol>
            <li>Initial: <b>Acyclovir 400 mg TID for 7–10 days</b> or valacyclovir/famciclovir equivalents.</li>
            <li>Recurrent: <b>5-day regimens</b> or episodic therapy within 48 hours of prodrome.</li>
            <li>Suppressive therapy indicated for ≥6 recurrences/year or in discordant couples.</li>
        </ol>
    </div>
    
    <div class="question-card">
        <h1>Question 2</h1>
        <p>What is the preferred diagnostic test for suspected genital herpes in active lesions?</p>
        <ul class="options" id="options">
            <li data-answer="correct">PCR of lesion swab</li>
            <li data-answer="wrong">Viral culture only</li>
            <li data-answer="wrong">Serologic IgM titer</li>
        </ul>
    </div>
    
    <div class="question-card">
        <h1>Question 3</h1>
        <p>Which of the following is NOT a typical complication of primary HSV infection?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Urinary retention</li>
            <li data-answer="wrong">Autoinoculation</li>
            <li data-answer="correct">Chronic cervicitis</li>
        </ul>
    </div>
    
    <div class="explanation-card">
        <h1>HIV/AIDS</h1>
        <h2>Human Immunodeficiency Virus: Virology and Disease Progression</h2>
        <h3>Virology and Transmission</h3>
        <p>HIV is a <b>retrovirus</b> of the Lentivirus genus. It primarily infects <b>CD4+ T helper cells</b>, macrophages, and dendritic cells. Transmission occurs via <b>blood, semen, vaginal secretions, rectal fluids, and breast milk</b>. Routes include <b>unprotected sexual contact</b>, <b>IV drug use</b>, <b>transfusions</b> (rare), and <b>vertical transmission</b>.</p>
        <h3>Natural History</h3>
        <ol>
            <li><b>Acute HIV syndrome</b> (2–4 weeks post-infection): fever, sore throat, rash, lymphadenopathy, mucocutaneous ulcers.</li>
            <li><b>Clinical latency</b>: asymptomatic for years; gradual CD4 decline.</li>
            <li><b>AIDS</b>: CD4 count < 200/mm³ or presence of AIDS-defining illness (e.g., Pneumocystis pneumonia, Kaposi’s sarcoma).</li>
        </ol>
        <h3>Diagnosis</h3>
        <ol>
            <li>Screening: <b>4th-generation ELISA</b> (p24 antigen + HIV-1/2 antibodies).</li>
            <li>Confirmation: <b>HIV-1 RNA PCR</b> or Western blot.</li>
            <li>Monitoring: <b>CD4 count</b> and <b>viral load</b> every 3–6 months.</li>
        </ol>
        <h3>Treatment</h3>
        <ol>
            <li><b>Antiretroviral therapy (ART)</b> recommended for all, regardless of CD4 count.</li>
            <li>Standard regimen: <b>2 NRTIs + 1 integrase inhibitor</b> (e.g., tenofovir/emtricitabine + dolutegravir).</li>
            <li>Prophylaxis for opportunistic infections based on CD4 thresholds (e.g., TMP-SMX for PCP at CD4 < 200).</li>
        </ol>
    </div>
    
    <div class="question-card">
        <h1>Question 4</h1>
        <p>Which finding most accurately defines AIDS?</p>
        <ul class="options" id="options">
            <li data-answer="correct">CD4 < 200/mm³ or AIDS-defining illness</li>
            <li data-answer="wrong">Positive HIV ELISA</li>
            <li data-answer="wrong">Presence of lymphadenopathy and fever</li>
        </ul>
    </div>
    
    <div class="question-card">
        <h1>Question 5</h1>
        <p>What is the first-line combination for initial HIV treatment in most patients?</p>
        <ul class="options" id="options">
            <li data-answer="correct">2 NRTIs + 1 integrase inhibitor</li>
            <li data-answer="wrong">Protease inhibitor monotherapy</li>
            <li data-answer="wrong">AZT only</li>
        </ul>
    </div>

    <div class="placeholder" id="empty">Test</div>

</div>